08:00 , Mar 29, 2004 |  BioCentury  |  Strategy

All that Jazz . . .

All that Jazz . . . Company Raised Date Focus Investors Jazz $250.0 3/24/04 Neurology, cancer, endocrine Kohlberg Kravis Roberts; Prospect Venture Partners; Versant Ventures; Beecken Petty O'Keefe; Golden Gate Capital; Thoma Cressey Equity Partners;...
07:00 , Apr 28, 2003 |  BioCentury  |  Finance

Ebb & Flow

Those who need a reminder of where the life science earnings growth is needn't look farther than last week's wave of biotech and pharma earnings. Outside of Pfizer (PFE) and specialty pharma play Forest (FRX),...
08:00 , Jan 13, 2003 |  BioCentury  |  Finance

Ebb & Flow

Choosing the right CEO to turn around a troubled biotech company is hardly a science, but the general wisdom is that a minimum requirement is experience building a drug company. Thus it came as a...
08:00 , Mar 18, 2002 |  BioCentury  |  Finance

Ebb & Flow

The quiet shuttering of the doors at DoubleTwist serves as a reminder that even smart money can get cooked when chasing the latest trend. On the promise of the marriage between information technology and life...
08:00 , Jan 7, 2002 |  BioCentury  |  Finance

Foresight in hindsight

Foresight in hindsight To mark the 10th Anniversary of the Buyside View, we have picked selected quotes from previous years - some prescient, others providing interesting historical perspective - and printed them below along with...
07:00 , Oct 22, 2001 |  BioCentury  |  Finance

Ebb & Flow

Trading in Genzyme (GENZ) provided for some read as to how the market weighs current EPS vs. potential future profits. GENZ's solid third quarter results and a boost in revenue projections for its Renagel phosphate...
07:00 , Sep 10, 2001 |  BioCentury  |  Finance

Ebb & Flow

A big week for FDA panel reviews will provide a major test for the biotech space in the wake of last week's post-Labor Day let-down. The big newsmakers will be Tuesday's Oncologic Drugs Advisory Committee...
07:00 , Sep 7, 2001 |  BC Extra  |  Financial News

Locus raises $28 million

Locus Discovery (Princeton, N.J.) raised $28 million in a venture financing. The company has an option to raise up to an additional $12 million in the financing round. Investors included Wanger Asset Management; ING Furman...
07:00 , Jul 23, 2001 |  BioCentury  |  Emerging Company Profile

Corporate Profile

CancerVax Corp. Carlsbad, Calif. Technology: Allogeneic whole cell cancer vaccines Disease focus: Cancer Clinical status: Phase III Founded: 2000 by Donald Morton Corporate partners: None University collaborators: John Wayne Cancer Institute Number of employees: 60...
07:00 , Jul 23, 2001 |  BioCentury  |  Emerging Company Profile

Corporate Profile

CancerVax Corp. Carlsbad, Calif. Technology: Allogeneic whole cell cancer vaccines Disease focus: Cancer Clinical status: Phase III Founded: 2000 by Donald Morton Corporate partners: None University collaborators: John Wayne Cancer Institute Number of employees: 60...